Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $778.00 | 1 | 51.3% |
| Food and Beverage | $738.36 | 17 | 48.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $968.83 | 4 | $0 (2020) |
| GlaxoSmithKline, LLC. | $162.85 | 6 | $0 (2023) |
| Travere Therapeutics, Inc. | $137.10 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $103.77 | 1 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $67.86 | 3 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $42.62 | 1 | $0 (2021) |
| Amgen Inc. | $33.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.87 | 3 | Travere Therapeutics, Inc. ($137.10) |
| 2023 | $53.74 | 2 | GlaxoSmithKline, LLC. ($53.74) |
| 2022 | $133.95 | 5 | GlaxoSmithKline, LLC. ($109.11) |
| 2021 | $85.64 | 3 | AKEBIA THERAPEUTICS INC ($43.02) |
| 2020 | $778.00 | 1 | AstraZeneca Pharmaceuticals LP ($778.00) |
| 2019 | $224.16 | 4 | AstraZeneca Pharmaceuticals LP ($190.83) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $39.11 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $97.99 | General |
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $103.77 | General |
| Category: NEPHROLOGY | ||||||
| 02/27/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $34.77 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Nephrology | ||||||
| 11/30/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Nephrology | ||||||
| 11/12/2021 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $42.62 | General |
| 08/24/2021 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Nephrology | ||||||
| 11/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Consulting Fee | Cash or cash equivalent | $778.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $91.42 | General |
| 11/09/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.10 | General |
| 11/08/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $33.33 | General |
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $86.31 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 335 | 668 | $264,133 | $84,191 |
| 2022 | 7 | 343 | 715 | $309,293 | $99,957 |
| 2021 | 9 | 337 | 702 | $300,601 | $109,816 |
| 2020 | 7 | 418 | 811 | $331,899 | $109,323 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 18 | 112 | $93,060 | $30,775 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 245 | $42,406 | $15,477 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 95 | $50,173 | $13,013 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 137 | $41,109 | $12,792 | 31.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 17 | 37 | $25,465 | $8,553 | 33.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 15 | $4,490 | $1,473 | 32.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $4,671 | $1,055 | 22.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $2,759 | $1,052 | 38.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 22 | 149 | $124,798 | $43,369 | 34.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 106 | $59,416 | $15,867 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 96 | 251 | $41,500 | $14,407 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 144 | $43,760 | $13,821 | 31.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 15 | 38 | $26,364 | $9,268 | 35.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $8,730 | $1,949 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,725 | $1,275 | 27.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 23 | 180 | $128,596 | $53,488 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 84 | 176 | $47,392 | $17,403 | 36.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 87 | 90 | $51,680 | $13,824 | 26.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 33 | $19,935 | $7,982 | 40.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 59 | 130 | $21,976 | $7,499 | 34.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 24 | 35 | $9,379 | $3,024 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 29 | $7,066 | $2,460 | 34.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 17 | 17 | $9,894 | $2,456 | 24.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,683 | $1,681 | 35.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 27 | 207 | $139,104 | $48,566 | 34.9% |
About Dr. John O'bell, MD
Dr. John O'bell, MD is a Hospitalist healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982657805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John O'bell, MD has received a total of $1,516 in payments from pharmaceutical and medical device companies, with $240.87 received in 2024. These payments were reported across 18 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($778.00).
As a Medicare-enrolled provider, O'bell has provided services to 1,433 Medicare beneficiaries, totaling 2,896 services with total Medicare billing of $403,287. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Other Specialties Nephrology, Nephrology
- Location Riverside, RI
- Active Since 05/19/2006
- Last Updated 01/22/2025
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1982657805
Products in Payments
- FARXIGA (Drug) $778.00
- BENLYSTA (Biological) $162.85
- JYNARQUE (Drug) $103.77
- Auryxia (Drug) $67.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Riverside
Dr. Errajith Bertrand Desilva, M.d, M.D
Hospitalist — Payments: $1,536
Adnan Misellati, M.d, M.D
Hospitalist — Payments: $1,105
Mousa Matar, M.d, M.D
Hospitalist — Payments: $986.69
Calvin Patel, Md, MD
Hospitalist — Payments: $955.75
Lauren Laughman, Md, MD
Hospitalist — Payments: $121.98
Andre Sahakian
Hospitalist — Payments: $72.05